Distribution nasal spray
Pharmacological action of
decongestant – alpha-adrenergic agonist
Acute respiratory infections with rhinitis (runny nose), acute allergic rhinitis, hay fever, sinusitis, eustachitis, otitis media (to reduce swelling of the mucous membrane of the nasopharynx).
Preparing the patient for diagnostic procedures in the nasal passages.
Diabetes mellitus, prostatic hyperplasia, coronary heart disease (angina pectoris), pheochromocytoma, hyperthyroidism, lactation with increased sensitivity to adrenergic drugs, accompanied by insomnia, dizziness, arrhythmia, tremor, and tremor.
Use during pregnancy and lactation
The use of the drug during pregnancy is contraindicated.
It is possible to use the drug during breastfeeding as prescribed by the attending physician if the expected therapeutic effect in the mother outweighs the risk of developing possible side effects in the baby.
Avoid contact with the eyes.
To avoid the spread of infection, you must use the drug individually.
Do not exceed recommended doses and use the drug for a long (more than 7 days) time. Long-term use of the drug can cause a rebound effect (drug rhinitis), the risk of reactive hyperemia and atrophy of the nasal mucosa increases.
Since the drug contains benzalkonium chloride as a preservative, especially with prolonged use (more than 7 days), swelling of the nasal mucosa can develop. If you suspect a similar reaction (nasal congestion), it is necessary, if possible, to use a drug that does not contain preservatives. If such drugs are not available, you must use a different dosage form.
1 dose (140 ?l) of the preparation contains:
hydrochloride l chloride – 14.0 ?g
Disodium edetate (Trilon B) – 70.0 ?g
Sodium hydrogen phosphate dihydrate – 280.0 ?g
Sodium dihydrogen phosphate dihydrate – 280.0 ?g
Sodium chloride – 1020.0 ?g
Water for injection – 138 , 75 mg
With frequent and / or prolonged use – irritation and / or dryness of the nasopharyngeal mucosa, burning, tingling, sneezing, hypersecretion of the nasopharyngeal mucosa, hypersensitivity reactions, swelling of the nasal mucosa, feeling of palpitations, tachycardia, and blood pressure, headache, nausea, vomiting, insomnia, impaired vision, depression (with prolonged use of high doses).
If any of the side effects indicated in the instructions are aggravated or you notice any other side effects not listed in the instructions, inform your doctor.
Xylometazoline should not be used in patients receiving therapy with monoamine oxidase inhibitors and tricyclic antidepressants (including the period of 14 days after their withdrawal) due to the possibility of increased blood pressure.
Symptoms: increased side effects (dose-dependent), decreased body temperature, confusion. In case of accidental ingestion, the drug may cause: severe dizziness, increased sweating, headache, bradycardia, increased blood pressure, respiratory depression, coma and cramps. After an increase in blood pressure, a sharp decrease can be observed.
Terms and conditions otpuska IZ drugstore
spray n azalic
Grotex Ltd. LLC, Russia